... drug Adcirca from Eli Lilly and Company. Following the final US Food and Drug Administration (FDA) approval for Tadalafil Tablets' Abbreviated New Drug Application (ANDA), ...
... solutions for glaucoma, announced today that it received Food and Drug Administration (FDA) approval for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device used ...
... (NASDAQ:REGN) today announced that due to ongoing labeling discussions the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the ...
... patents relating to Apleek have been registered in the United States, the European Union, China, Japan and a number of other countries and regions. With ...
... with the previously announced sale of the ZOMAJET needle-free delivery system. Announced FDA accepted our resubmission to the Complete Response Letter received in connection with ...
... second quarter of 2017. The majority of this increase resulted from higher SPOT service revenue, which grew $ 2.7 million due to increases in ARPU ...
... well as up to $52 million in payments contingent upon U.S. Food and Drug Administration (FDA) approval of the VICI stent system. Venous obstructive disease ...
... Search(TM), our Automated Fingerprint Identification System and related services to the Zimbabwe Electoral Commission ("ZEC").Net loss for the three and six months was $2.5 million ...
... nutraceutical and cosmetic products. The Company recently announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S. Application ...
